Is IZZ Worth Holding as US-China Trade Tensions Escalate?

The iShares China Large-Cap ETF (ASX: IZZ) has dropped approximately 10% since January 2026, raising the question of whether this drawdown is a warning or a rare entry point into China's largest listed companies for ASX investors.
By Branka Narancic -
iShares China Large-Cap ETF IZZ showing -5.59% YTD return and $51.10 unit price with Alibaba, Tencent, Xiaomi holdings

Key Takeaways

  • The iShares China Large-Cap ETF (ASX: IZZ) has fallen approximately 10.3% since January 2026, with a year-to-date total return of approximately -5.59% as of 28 April 2026, creating a live entry timing question for investors.
  • IZZ tracks 50 Hong Kong-listed Chinese large-caps, with Alibaba, Tencent, and Xiaomi comprising more than 25% of the portfolio, giving the fund a heavy tilt toward China's digital and industrial economy.
  • Over its 22-year history since 2004, IZZ has delivered an annualised return of 5.63% alongside a trailing dividend yield of approximately 2.15%, establishing a moderate but meaningful long-run compounding track record.
  • Chinese companies in IZZ's portfolio are structurally obligated to prioritise state directives over shareholder returns, a governance risk that is permanent rather than cyclical and does not appear in the fund's fact sheet.
  • With approximately $495 million in funds under management, IZZ is the largest and most liquid ASX-listed China ETF, giving it a practical advantage over peers CETF and CNEW in terms of bid-ask spreads and institutional adoption.

Since early January 2026, the iShares China Large-Cap ETF (ASX: IZZ) has shed approximately 10% of its value. For some ASX investors, that drawdown is a warning sign. For others, it is the entry point they have been watching for.

The tension between those two readings captures the broader question facing Australian retail investors right now. With US-China trade tensions generating reciprocal tariffs of up to 145% and 125% respectively, and the US dollar’s dominance facing its most serious questions in decades, geographic allocation is no longer a set-and-forget decision. Chinese equities, long treated as a satellite bet, are attracting renewed scrutiny as a potential counterweight to US market concentration.

This analysis unpacks what IZZ actually holds, how it has performed, what it costs relative to its ASX peers, what structural risks are embedded in the fund, and how investors should weigh those factors given the current macro environment.

The case for looking east: Why Chinese equities are back on ASX radar

The conversation starts with tariffs, but it does not end there. Through 2025 and into 2026, US-China trade escalation pushed reciprocal duties to levels that would have seemed implausible two years ago.

US tariffs on Chinese goods have reached 145%. China’s retaliatory tariffs on US imports stand at 125%. These figures represent the sharpest bilateral trade barriers between the world’s two largest economies in the modern era.

That escalation has coincided with a broader erosion of confidence in US global institutional leadership, prompting Australian allocators to reconsider portfolios heavily weighted toward US equities. China’s position as the world’s second-largest economy, with stated superpower ambitions and a 2026 GDP growth target of 4.5%-5%, provides the macroeconomic frame.

What sharpens the investment case beyond GDP figures is China’s industrial positioning in the sectors that are likely to define the next decade of global growth:

  • World leader in electric vehicle manufacturing and export
  • Dominant processor of rare earth minerals used across technology and defence supply chains
  • Largest installer and manufacturer of renewable energy infrastructure

Beijing has deployed stimulus measures to offset trade headwinds, and that policy support underpins the earnings outlook for the large-cap companies IZZ tracks. The question for ASX investors is whether those credentials translate into portfolio returns, or whether the geopolitical discount absorbs them.

How IZZ is structured and what it actually owns

IZZ tracks 50 of China’s largest companies listed on the Hong Kong Stock Exchange. That distinction matters. This is not mainland A-share exposure, where companies trade on the Shanghai or Shenzhen exchanges under tighter capital controls. Hong Kong-listed Chinese large-caps are accessible to international capital flows, dual-listed in many cases, and subject to Hong Kong’s regulatory framework alongside mainland obligations.

The portfolio’s character becomes clearer through its largest positions.

Holding Approximate portfolio weight
Alibaba 9.01%
Tencent 8.16%
Xiaomi 7.97%
BYD Top 10 holding
Meituan Top 10 holding

The top three names alone account for more than 25% of the fund, giving IZZ a meaningful concentration in Chinese technology and consumer platforms. Investors familiar with these businesses through global media coverage will recognise the portfolio’s tilt toward China’s digital and industrial economy.

IZZ Portfolio Concentration: Top Holdings Breakdown

Key fund mechanics at a glance:

  • Management fee: 0.60% per annum
  • Dividend frequency: Semi-annual; trailing annual dividend of approximately $1.11 (yield of approximately 2.15%); most recent distribution of $0.471 in December 2025
  • Funds under management: Approximately $494.6 million as of 29 April 2026
  • Inception: 2004, giving the fund a 22-year operating history

IZZ’s performance record: What the numbers reveal about long-run returns and recent volatility

Long-run annualised return since inception

Over 22 years of operation, IZZ has delivered an annualised return of 5.63% to 31 March 2026.

5.63% annualised since 2004. That figure captures multiple cycles of Chinese market volatility, including the 2008 global financial crisis, the 2015 mainland equity sell-off, the COVID-19 drawdown, and the regulatory crackdowns of 2021. It is a reference point for long-run expectations, not a guarantee.

That baseline establishes IZZ as a fund with a meaningful, if moderate, track record of compounding returns across dramatically different market environments. The 2.15% trailing yield adds an income component that supplements capital returns.

2026 performance and the current entry price question

The gap between that long-run average and recent performance is sharp. In early January 2026, IZZ’s unit price closed at approximately $58.27. By early April 2026, prices ranged between approximately $50.64 and $52.28, representing a drawdown of approximately 10.3% in under three months.

The year-to-date total return as of 28 April 2026 stood at approximately -5.59%.

As of 30 April 2026, the unit price sat at approximately $51.10, against a net asset value (NAV) of $50.18 as of 28 April 2026. That narrow premium to NAV is a practical data point for investors evaluating whether the current market price reflects fair value or whether the drawdown has created a discount worth acting on. The difference between $51.10 and $50.18 suggests the market is pricing IZZ close to its underlying portfolio value, with no significant premium or discount distortion.

How IZZ compares to other China ETFs on the ASX

Australian investors searching for China exposure on the ASX will encounter three primary options. The structural differences between them are more significant than the headline fees suggest.

ASX China ETFs: IZZ vs CETF vs CNEW

Fund Management fee FUM (approx.) Dividend yield (approx.) Index universe
IZZ (iShares) 0.60% $495M 2.15% 50 HK-listed large-caps
CETF (VanEck) 0.60% Not disclosed Not disclosed 50 mainland A-share large-caps
CNEW (VanEck) Not disclosed $80.74M 0.90% New economy growth sectors

IZZ and CETF both charge 0.60%, but they track entirely different universes. IZZ holds Hong Kong-listed giants like Alibaba and Tencent; CETF holds the 50 largest mainland A-share companies, which trade under different capital controls and regulatory structures. Fee parity alone is a misleading comparison criterion.

CNEW takes a thematic approach, targeting China’s new economy growth sectors. Its FUM of approximately $80.74 million is a fraction of IZZ’s $495 million, and its yield of approximately 0.90% reflects a growth-oriented portfolio that prioritises capital appreciation over income.

IZZ’s scale advantage matters for ASX retail investors. Higher FUM typically correlates with tighter bid-ask spreads and greater institutional adoption, both of which reduce friction for investors entering or exiting positions.

The structural risks that do not appear in the fund’s fact sheet

State obligations and shareholder interests

Chinese-listed companies operate under governance obligations that differ from the frameworks ASX investors apply to domestic or US holdings. Businesses are required to prioritise state directives, which can influence dividend policy, capital allocation decisions, and strategic direction in ways that may not align with minority shareholder interests.

This is not a temporary regulatory environment. It is a structural feature of investing in Chinese equities. For ETF holders, it means the companies in IZZ’s portfolio may redirect capital toward state priorities even when shareholder returns would be better served by alternative uses.

Non-citizens cannot hold direct ownership stakes in Chinese-listed companies. ETF investors hold indirect exposure through the fund structure, which limits shareholder recourse in ways that differ from holding ASX-listed equities directly.

Regulatory reform: risk and opportunity in parallel

China’s securities regulator (CSRC) has outlined a 2026 reform agenda that encompasses market liberalisation and the development of stablecoin regulations in Hong Kong. Recent legislative changes have also reduced entry barriers for foreign fund investors.

These reforms represent both opportunity and uncertainty:

  • Opportunity: Regulatory maturation could attract additional international capital, improve market transparency, and strengthen investor protections over time
  • Uncertainty: An evolving ruleset means the regulatory environment IZZ’s holdings operate under today may look different within 12-18 months, and the direction of change is not guaranteed to favour foreign investors
  • Governance constraints: State-loyalty obligations remain embedded regardless of reform progress

Investors who understand these risks can size their allocation appropriately. Those who overlook them may find their risk-adjusted return assumptions tested.

China exposure in an ASX portfolio: sizing the opportunity against the risk

The analytical threads converge on a practical question: does IZZ belong in an Australian investor’s portfolio, and if so, how much?

The bull case anchors:

  • 22-year track record averaging 5.63% annualised returns through multiple market cycles
  • Trailing dividend yield of approximately 2.15%, providing an income component
  • FUM of approximately $495 million, the largest among ASX-listed China ETFs, signalling institutional adoption and liquidity
  • A macro environment in which institutional interest is rotating away from US equity concentration

The bear case anchors:

  • A 2026 drawdown of approximately 10.3% from January to April, demonstrating how rapidly trade escalation can reprice the fund
  • Year-to-date total return of approximately -5.59% as of 28 April 2026
  • State-loyalty governance constraints that are structural, not cyclical
  • China’s moderated GDP growth target of 4.5%-5% reflects genuine headwinds, not just conservative guidance

IZZ functions as a satellite allocation rather than a core holding. The appropriate sizing depends on an investor’s existing US and domestic equity concentration, risk tolerance, and view on the trajectory of US-China trade relations through 2026 and beyond. The 2028 US presidential election represents a potential inflection point in that trajectory, for better or worse.

The bottom line on IZZ for Australian investors in 2026

IZZ is a well-constructed, liquid, and cost-competitive vehicle for gaining exposure to China’s largest companies. Its 22-year track record, $495 million in funds under management, and 2.15% yield give it credible standing among ASX-listed China ETFs.

The structural governance risks and macro volatility mean it demands active portfolio positioning rather than passive treatment. The fund’s 10.3% drawdown since January and ongoing tariff uncertainty make current entry timing a live question. The NAV versus unit price relationship ($50.18 versus $51.10) is a practical data point to monitor in the weeks ahead.

Australian investors who already hold US-heavy equity portfolios and want a non-correlated, large-cap Asian allocation have a credible option in IZZ, provided they have digested the governance and geopolitical risk profile. Comparing IZZ against CETF and CNEW using the framework above, and reviewing IZZ’s latest product disclosure statement and BlackRock fund page for current holdings and distribution announcements, would be a sound next step before making an allocation decision.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.

Frequently Asked Questions

What is the iShares China Large-Cap ETF (ASX: IZZ)?

The iShares China Large-Cap ETF (ASX: IZZ) is an exchange-traded fund that tracks 50 of China's largest companies listed on the Hong Kong Stock Exchange, with top holdings including Alibaba, Tencent, and Xiaomi, and a management fee of 0.60% per annum.

How has IZZ performed in 2026?

IZZ has had a difficult start to 2026, falling approximately 10.3% from its January peak of around $58.27 to a range of $50.64-$52.28 by early April, with a year-to-date total return of approximately -5.59% as of 28 April 2026.

What are the main risks of investing in the iShares China Large-Cap ETF?

The key risks include structural governance obligations that require Chinese companies to prioritise state directives over shareholder returns, ongoing US-China trade tensions with tariffs reaching up to 145%, and an evolving regulatory environment that could change within 12-18 months in ways that may not favour foreign investors.

How does IZZ compare to other China ETFs available on the ASX?

IZZ is the largest ASX-listed China ETF with approximately $495 million in funds under management and a 2.15% yield, while VanEck's CETF tracks mainland A-share companies at the same 0.60% fee, and VanEck's CNEW focuses on new economy growth sectors with only $80.74 million in FUM and a 0.90% yield.

Is IZZ suitable as a core or satellite holding in an ASX portfolio?

IZZ is best suited as a satellite allocation rather than a core holding, appropriate for investors who already hold US-heavy equity portfolios and want a non-correlated large-cap Asian allocation, provided they understand the governance and geopolitical risk profile.

Branka Narancic
By Branka Narancic
Partnership Director
Bringing nearly a decade of capital markets communications and business development experience to StockWireX. As a founding contributor to The Market Herald, she's worked closely with ASX-listed companies, combining deep market insight with a commercially focused, relationship-driven approach, helping companies build visibility, credibility, and investor engagement across the Australian market.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher